Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
innovative digital solutions for a sustainable future. The successful applicant will need to meet Charles Sturt university and CSIRO Next generation Graduates program requirements for admission into the PhD
-
The key skills and experience of a Senior Research Officer include: Shall possess an MD or PhD degree in immunology, gastroenterology, genomics or another related field Experience with computational
-
(including patent-relevant work) What will you bring? A PhD in bioinformatics, computational biology or a parallel field such as immunology with demonstrated experience in bioinformatics An understanding
-
) Atomistic classical simulations of macromolecules (v) Biophysics. You can write computer codes to solve some of the daily research problems and have experience with high performance computing. You should have
-
and synthesis of new materials. You should have a PhD in a relevant field (Computer Science, Mathematics are most likely to fit the role, but we are open to Chemistry, Materials Science, Chemical
-
leading quantum computing company and their decarbonisation affiliate Qlimate. PsiQuantum is currently building a utility-scale quantum computer in Brisbane. The QDA aims to pioneer the use of quantum
-
silicon. We have established all the all the key results – high-fidelity quantum gates, exceptional coherence times, compatibility with large-scale manufacturing – that make semiconductor quantum computing
-
About The School The School of Electrical Engineering and Computer Science (EECS) at St Lucia is entering an exciting phase of growth, investing heavily in teaching, research, and engagement
-
contribute to extending the curriculum to teach the next generation of Computer Science, IT, and Engineering graduates in quantum computing. Candidates will ideally be able to demonstrate: Completion of a PhD
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural